Johnson & Johnson (JNJ) Shares Outstanding (2009 - 2026)

Johnson & Johnson has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $2.4 billion in Q2 2026.

• Quarterly Shares Outstanding (Entity) changed 0.05% year-over-year to $2.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.4 billion (changed 0.05% YoY) and the FY2025 annual result came in at $2.4 billion, changed 0.0% from the prior year.
• Shares Outstanding (Entity) held at $2.4 billion in Q2 2026 per JNJ's latest filing, from $2.4 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $3.1 billion in Q1 2022 and troughed at $2.4 billion in Q2 2025.
• A 5-year average of $2.7 billion and a median of $2.4 billion in 2026 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) decreased 22.81% in 2024, then increased 0.06% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $3.1 billion in 2022, then retreated by 18.79% to $2.5 billion in 2023, then dropped by 4.98% to $2.4 billion in 2024, then advanced by 0.0% to $2.4 billion in 2025, then changed by 0.0% to $2.4 billion in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $2.4 billion, $2.4 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.